This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Conduct disorder
F5_CONDUCT
conduct disorder: A disorder diagnosed in childhood or adolescence age group characterized by aggressive behavior, deceitfulness, destruction of property or violation of rules that is persistent and repetitive, and within a one year period.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
909 |
4. Check minimum number of eventsNone |
909 |
5. Include endpointsNone |
909 |
6. Filter based on genotype QC (FinnGen only) |
909 |
Control definitions (FinnGen only)
- Control exclude
- F5_BEHEMOCHILD
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- F90-F98
- Name in latin
- Perturbationes modi se gerendi
Similar endpoints
↥List of similar endpoints to
Conduct disorder
based on the number of shared cases.
Similar with more cases:
- Behavioural and emotional disorders with onset usually occurring in childhood and adolescence
- Any mental disorder
- Psychiatric diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 909 | 450 | 459 |
| Unadjusted period prevalence (%) | 0.18 | 0.15 | 0.20 |
| Median age at first event (years) | 14.58 | 14.86 | 14.30 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 826
- Matched controls
- 8262
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F91.9
ICD-10 Finland
Conduct disorder, unspecified
+∞
257.1
233
*
30899
ICD-8 Finland
Behaviour disorders of childhood
+∞
172.0
159
*
N05AH04
ATC
quetiapine; oral
7.9
139.2
393
850
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
8.3
128.0
333
620
F91.2
ICD-10 Finland
Socialized conduct disorder
+∞
120.9
113
*
N05AX08
ATC
risperidone; systemic
12.1
113.2
222
244
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
10.5
110.8
236
303
F92.0
ICD-10 Finland
Depressive conduct disorder
1173.2
107.9
103
*
F90.0
ICD-10 Finland
Disturbance of activity and attention
24.7
106.9
154
76
F91.1
ICD-10 Finland
Unsocialized conduct disorder
+∞
104.4
98
*
F91.0
ICD-10 Finland
Conduct disorder confined to the family context
+∞
103.3
97
*
T36
ICD-10 Finland
Poisoning by systemic antibiotics
12.6
97.0
184
184
F93.89
ICD-10 Finland
Other childhood emotional disorders
526.3
96.5
94
*
F92.9
ICD-10 Finland
Mixed disorder of conduct and emotions, unspecified
+∞
93.5
88
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
5.8
86.0
292
715
N05AH03
ATC
olanzapine; systemic
9.1
85.4
195
272
F91.3
ICD-10 Finland
Oppositional defiant disorder
+∞
84.9
80
*
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
9.9
83.6
180
226
N06BA04
ATC
methylphenidate; oral
16.2
71.6
119
85
F29
ICD-10 Finland
Unspecified nonorganic psychosis
8.9
70.8
161
218
N03AG01
ATC
valproic acid; systemic, rectal
9.1
70.8
159
211
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
11.1
66.0
131
138
N05AX12
ATC
aripiprazole; systemic
8.6
65.3
151
209
N05AA02
ATC
levomepromazine; systemic
14.6
64.6
112
88
F91.8
ICD-10 Finland
Other conduct disorders
+∞
64.4
61
*
N06AB03
ATC
fluoxetine; oral
6.0
59.9
184
379
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
15.2
59.0
100
74
N06AX11
ATC
mirtazapine; oral
3.7
57.8
332
1271
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
6.0
56.1
169
337
N05AF03
ATC
chlorprothixene; systemic
14.5
55.6
96
74
N05BA04
ATC
oxazepam; oral
3.9
55.0
277
943
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
22.6
53.4
78
38
F92.8
ICD-10 Finland
Other mixed disorders of conduct and emotions
551.8
53.1
52
*
N05BA01
ATC
diazepam; systemic, rectal
5.4
52.5
176
397
B18.2
ICD-10 Finland
Chronic viral hepatitis C
17.6
50.3
80
50
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
4.9
49.3
180
444
N06AB04
ATC
citalopram; systemic
4.2
49.2
219
658
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
4.3
49.1
213
624
N05AH02
ATC
clozapine; systemic
11.9
48.2
91
85
3120A
ICD-9 Finland
Disturbance of conduct not elsewhere classified, Undersocialised conduct disorder, aggressive type
+∞
47.3
45
*
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
5.6
44.9
143
300
N06AB06
ATC
sertraline; oral
4.3
42.7
176
485
N03AX09
ATC
lamotrigine; oral
6.8
42.4
113
188
Z72.2
ICD-10 Finland
Drug use
36.0
42.1
54
16
N07BB01
ATC
disulfiram; oral
8.2
40.5
94
127
F61.0
ICD-10 Finland
Mixed personality disorders
18.7
39.5
61
35
P29
ICPC
Psychological sympt/compl other
4.7
38.6
144
357
P19
ICPC
Drug abuse
12.9
38.3
69
58
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
9.3
36.9
79
93
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
20.6
36.2
54
28
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
3.7
35.0
170
535
F99
ICD-10 Finland
Mental disorder, not otherwise specified
9.1
34.4
74
88
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
11.5
34.3
65
61
T74.1
ICD-10 Finland
Physical abuse
7.6
34.2
83
120
N05CD07
ATC
temazepam; oral
6.2
33.9
96
172
P99
ICPC
Psychological disorders other
7.9
33.5
79
109
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
9.8
33.5
69
76
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
14.2
33.2
57
43
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
10.2
33.2
67
71
N05CF01
ATC
zopiclone; oral
3.1
32.9
218
861
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
8.5
32.6
73
93
N05AD01
ATC
haloperidol; systemic
12.1
32.6
60
53
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
6.1
32.5
92
165
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
11.3
32.5
62
59
F60.9
ICD-10 Finland
Personality disorder, unspecified
15.1
32.4
54
38
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
12.1
32.1
59
52
N05AN01
ATC
lithium; oral
10.2
30.4
61
64
F60.2
ICD-10 Finland
Dissocial personality disorder
43.0
30.2
37
9
N06AX16
ATC
venlafaxine; oral
3.3
29.9
168
586
F20.9
ICD-10 Finland
Schizophrenia, unspecified
8.9
29.5
64
77
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
6.5
29.5
80
135
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
8.7
28.3
62
76
K02.1
ICD-10 Finland
Caries of dentine
2.3
28.0
586
4212
N06AB10
ATC
escitalopram; oral
2.7
27.6
238
1094
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
6.1
27.1
76
134
F19.21
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment
33.1
27.0
35
11
IGV01
NOMESCO Finland
Psychiatric network contact
16.7
27.0
43
27
EBA00
NOMESCO Finland
Extraction of tooth
2.3
26.9
373
2190
EB1AA
NOMESCO Finland
Tooth X-ray examination
2.2
26.7
483
3203
SAA01
NOMESCO Finland
Simple examination of mouth
2.5
26.5
667
5173
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
14.9
26.4
44
31
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
5.5
26.0
80
158
P18
ICPC
Medication abuse
18.2
25.9
40
23
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
25.0
25.9
36
15
T51.0
ICD-10 Finland
Toxic effect: Ethanol
22.7
25.8
37
17
N05AA01
ATC
chlorpromazine; systemic, rectal
16.5
25.7
41
26
F10.09
ICD-10 Finland
Alcohol intoxication UNS
7.2
25.6
63
93
EBA05
NOMESCO Finland
Complicated extraction of tooth
2.8
25.4
189
792
F19.25
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances continuously used
36.9
25.4
32
9
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.3
25.3
334
1901
N05BA06
ATC
lorazepam; systemic, sublingual
7.3
25.3
62
91
C07AA05
ATC
propranolol; systemic
2.8
24.8
190
807
S06.0
ICD-10 Finland
Concussion
3.1
24.4
149
547
P72
ICPC
Schizophrenia
9.3
24.4
51
58
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
5.4
24.3
76
153
F93.9
ICD-10 Finland
Childhood emotional disorder, unspecified
+∞
24.1
23
*
F90.9
ICD-10 Finland
Hyperkinetic disorder, unspecified
38.8
24.1
30
8
331
Kela drug reimbursment
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
23.6
24.1
34
15
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
5.3
23.9
76
156
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
22.1
23.6
34
16
AA1AD
NOMESCO Finland
CT of head and brain
3.0
23.5
149
561
WX110
NOMESCO Finland
Local anesthesy
2.3
23.2
631
4867
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.6
23.2
197
886
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
6.8
23.1
59
92
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
16.1
23.0
37
24
M54.5
ICD-10 Finland
Low back pain
2.3
23.0
270
1438
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
67.0
22.9
26
*
M79.6
ICD-10 Finland
Pain in limb
2.3
22.9
268
1424
R5599
NOMESCO Finland
Other rehabilitation service
8.2
22.6
51
66
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
11.0
22.6
43
41
N03AX12
ATC
gabapentin; oral
3.5
22.6
115
369
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
17.3
22.4
35
21
N03AE01
ATC
clonazepam; systemic
5.2
22.1
71
148
F90.1
ICD-10 Finland
Hyperkinetic conduct disorder
+∞
22.0
21
*
R51.80
ICD-10 Finland
Headache
2.6
21.9
178
778
Z72.8
ICD-10 Finland
Other problems related to lifestyle
19.0
21.9
33
18
IGY02
NOMESCO Finland
Psychiatric monitoring contact
5.6
21.8
65
124
F98.8
ICD-10 Finland
Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
225.7
21.7
22
*
IGY99
NOMESCO Finland
Other psychiatric treatment contact
6.5
21.6
57
93
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
2.0
21.4
442
2980
P15
ICPC
Chronic alcohol abuse
6.3
21.4
58
98
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.8
21.3
157
646
N04AA02
ATC
biperiden; systemic
10.7
21.3
41
40
F10.20
ICD-10 Finland
Alcohol dependence currently independent
8.6
21.2
46
56
-1
NOMESCO Finland
NA
2.0
21.0
400
2606
SPAT1254
SPAT
Administration of medicine
2.6
20.9
172
756
F12.1
ICD-10 Finland
Mental and behavioural disorders due to use of cannabinoids, harmful use
15.4
20.8
34
23
F43.1
ICD-10 Finland
Post-traumatic stress disorder
5.6
20.8
62
118
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
7.6
20.8
49
68
N05AB03
ATC
perphenazine; systemic, rectal
6.7
20.5
53
84
N03AF01
ATC
carbamazepine; oral, rectal
6.0
20.5
57
100
N05BA12
ATC
alprazolam; oral
3.9
20.4
88
245
A28
ICPC
Limited function/disability NOS
4.2
20.3
80
206
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
12.5
20.2
36
30
X78
ICD-10 Finland
Intentional self-harm by sharp object
14.1
20.2
34
25
F51.0
ICD-10 Finland
Nonorganic insomnia
2.7
20.0
147
604
K04.0
ICD-10 Finland
Pulpitis
2.9
19.9
133
513
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.6
19.8
158
680
F41.1
ICD-10 Finland
Generalized anxiety disorder
3.6
19.6
93
281
P16
ICPC
Acute alcohol abuse
8.1
19.5
44
57
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
6.7
19.4
50
79
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
32.2
19.3
25
8
Z71.8
ICD-10 Finland
Other specified counselling
2.2
19.3
248
1354
F39
ICD-10 Finland
Unspecified mood [affective] disorder
6.4
19.2
51
84
Z04.4
ICD-10 Finland
Examination and observation following alleged rape and seduction
16.3
18.9
30
19
A46
ICD-10 Finland
Erysipelas
3.5
18.8
93
290
F98.9
ICD-10 Finland
Unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
+∞
18.8
18
*
F10.25
ICD-10 Finland
Alcohol dependence continuous use
9.0
18.6
39
45
N05AF05
ATC
zuclopenthixol; systemic
15.5
18.6
30
20
F10.24
ICD-10 Finland
Alcohol depence active use
10.4
18.5
36
36
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
3.2
18.4
102
346
K04.08
ICD-10 Finland
Other specified pulpit
3.3
18.4
99
330
SPAT1272
SPAT
Drug screening
14.0
18.4
31
23
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
6.7
18.3
47
74
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
25.7
18.3
25
10
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
22.3
18.3
26
12
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
4.1
18.2
72
186
O04.9
ICD-10 Finland
Medical abortion, complete or unspecified, without complication
3.1
18.1
106
374
N03AX16
ATC
pregabalin; oral
2.6
18.0
150
660
C07AB07
ATC
bisoprolol; oral
2.3
17.9
198
1004
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
2.2
17.9
212
1113
Z63.5
ICD-10 Finland
Disruption of family by separation and divorce
20.6
17.8
26
13
F84.5
ICD-10 Finland
Asperger syndrome
12.8
17.7
31
25
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.4
17.7
88
276
Z10.1
ICD-10 Finland
Routine general health check-up of inhabitants of institutions
97.2
17.6
19
*
SGA01
NOMESCO Finland
Tooth opening as first aid
2.4
17.6
173
827
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
7.3
17.6
42
60
30180
ICD-8 Finland
Personality disorders, Immatura
43.0
17.3
21
5
Z61.8
ICD-10 Finland
Other negative life events in childhood
32.2
17.1
22
7
3094A
ICD-9 Finland
Adjustment reaction, With mixed disturbance of emotions and conduct
51.1
17.0
20
*
N06AA12
ATC
doxepin; systemic
7.3
16.8
40
57
P01AB01
ATC
metronidazole; oral, rectal
2.0
16.7
254
1475
3123D
ICD-9 Finland
Disturbance of conduct not elsewhere classified, Disorders of impulse control, not elsewhere classified[TOISTUVAT RAIVOKOHTAUKSET]
+∞
16.7
16
*
X45
ICD-10 Finland
Accidental poisoning by and exposure to alcohol
18.4
16.5
25
14
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
18.4
16.5
25
14
SPAT1240
SPAT
Therapeutic discussion
2.4
16.5
158
745
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
20.6
16.5
24
12
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
5.7
16.4
47
86
N06AX12
ATC
bupropion; oral
3.1
16.4
94
328
IEV99
NOMESCO Finland
Other psychiatric network intervention
13.1
16.2
28
22
WX290
NOMESCO Finland
Other blockade of nerve
1.8
16.1
468
3424
N05BA02
ATC
chlordiazepoxide; systemic
8.5
16.1
35
43
N05BE01
ATC
buspirone; oral
6.2
16.1
43
72
RS310
NOMESCO Finland
NA
48.5
16.1
19
*
RS214
NOMESCO Finland
NA
25.0
16.1
22
9
S18
ICPC
Laceration/cut
2.0
16.0
274
1663
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.2
16.0
190
993
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
8.3
15.9
35
44
N02BE01
ATC
paracetamol; systemic, rectal
1.9
15.9
602
4818
L03
ICPC
Low back symptom/complaint
2.2
15.9
197
1049
P01
ICPC
Feeling anxious/nervous/tense
2.2
15.8
181
930
P23
ICPC
Adolescent behaviour sympt/compl
12.0
15.6
28
24
N01
ICPC
Headache
2.2
15.5
183
950
F19.00
ICD-10 Finland
Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated
38.8
15.4
19
5
RT250
NOMESCO Finland
NA
38.8
15.4
19
5
F25.00
ICD-10 Finland
Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms
16.4
15.3
24
15
F60.8
ICD-10 Finland
Other specific personality disorders
18.2
15.2
23
13
3018X
ICD-9 Finland
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
20.5
15.2
22
11
KMAK
NOMESCO Finland
NA
1.8
15.2
436
3152
D11
ICPC
Diarrhoea
2.4
15.0
144
679
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.5
14.9
71
216
R4140
NOMESCO Finland
Psychotherapy
11.6
14.9
27
24
F61
ICD-10 Finland
Mixed and other personality disorders
32.4
14.8
19
6
N17
ICPC
Vertigo/dizziness
3.0
14.8
88
311
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.8
14.8
482
3621
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.0
14.8
92
336
P06
ICPC
Sleep disturbance
2.7
14.7
107
433
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
12.2
14.6
26
22
F93.80
ICD-10 Finland
Generalized anxiety in the bardom age
+∞
14.6
14
*
F94.1
ICD-10 Finland
Reactive attachment disorder of childhood
+∞
14.6
14
*
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
6.4
14.6
38
62
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.4
14.5
71
220
N06BA09
ATC
atomoxetine; oral
152.6
14.5
15
*
XF400
NOMESCO Finland
ECG with 12 standard connections
2.6
14.5
115
489
Z63.2
ICD-10 Finland
Inadequate family support
36.7
14.5
18
5
D01
ICPC
Abdominal pain/cramps general
2.4
14.5
129
585
N02AX02
ATC
tramadol; systemic, rectal
2.0
14.4
233
1374
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.6
14.3
114
485
F19.9
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder
19.5
14.3
21
11
K08.3
ICD-10 Finland
Retained dental root
4.0
14.3
57
149
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.8
14.2
481
3634
G40.9
ICD-10 Finland
Epilepsy, unspecified
5.0
14.1
45
94
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
5.7
14.1
40
73
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
7.0
14.0
34
50
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.0
14.0
200
1119
L17
ICPC
Foot/toe symptom/complaint
2.1
14.0
191
1052
Z91.5
ICD-10 Finland
Personal history of self-harm
30.6
13.9
18
6
LCH11
NOMESCO Finland
Pharmacologic abortion
3.4
13.9
68
211
R07.4
ICD-10 Finland
Chest pain, unspecified
2.3
13.9
146
717
Z63.8
ICD-10 Finland
Other specified problems related to primary support group
24.3
13.8
19
8
F34.1
ICD-10 Finland
Dysthymia
4.5
13.7
49
115
F83
ICD-10 Finland
Mixed specific developmental disorders
6.8
13.7
34
52
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
8.5
13.6
29
35
R41.0
ICD-10 Finland
Disorientation, unspecified
9.6
13.5
27
29
30799
ICD-8 Finland
Transient situational disturbances
142.2
13.5
14
*
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
7.2
13.4
32
46
SPAT1307
SPAT
Psychosocial counselling and guidance
2.4
13.3
121
550
SPAT1234
SPAT
Support of social functional capacity
4.7
13.3
45
100
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
3.3
13.3
69
224
J01FF01
ATC
clindamycin; systemic
2.0
13.2
186
1034
P74
ICPC
Anxiety disorder/anxiety state
3.2
13.1
69
226
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
15.4
13.1
21
14
D10
ICPC
Vomiting
2.6
13.1
104
441
N06BA12
ATC
lisdexamfetamine; oral
23.0
12.9
18
8
3004A
ICD-9 Finland
Neurotic disorders, Neurotic depression
50.8
12.9
15
*
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
7.4
12.9
30
42
F41.8
ICD-10 Finland
Other specified anxiety disorders
4.0
12.8
51
133
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.0
12.7
199
1148
F15.5
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder
32.6
12.6
16
5
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.2
12.6
143
724
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
10.3
12.5
24
24
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.8
12.5
85
330
3123X
ICD-9 Finland
Disturbance of conduct not elsewhere classified, Disorders of impulse control, not elsewhere classified[TARKEMMIN MÄÄRITTELEMÄTÖN HILLITSEMISHÄIRIÖ]
+∞
12.5
12
*
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
5.6
12.5
36
67
F19.26
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances periodic addiction
24.7
12.5
17
7
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
3.8
12.5
53
147
30088
ICD-8 Finland
Neuroses, Other
131.9
12.5
13
*
R42
ICD-10 Finland
Dizziness and giddiness
2.3
12.4
120
564
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.6
12.4
94
390
N07BA03
ATC
varenicline; oral
3.6
12.4
56
164
S76
ICPC
Skin infection other
4.4
12.3
44
104
F13.25
ICD-10 Finland
Addiction caused by sedative and hypnotic continuous use
14.6
12.3
20
14
F11.29
ICD-10 Finland
Addiction caused by opiates UNS
14.6
12.3
20
14
N06AB05
ATC
paroxetine; oral
3.6
12.3
56
165
P76
ICPC
Depressive disorder
2.7
12.2
87
348
IGP01
NOMESCO Finland
Psychiatric family contact
7.1
12.2
29
42
Z00.0
ICD-10 Finland
General medical examination
2.0
12.2
169
930
SGA03
NOMESCO Finland
Demanding opening and dilatation of root canal of tooth
2.6
12.1
95
400
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.8
12.1
268
1743
F20.10
ICD-10 Finland
Raise schizophrenia continuously
18.4
12.1
18
10
X59
ICD-10 Finland
Exposure to unspecified factor
2.0
12.1
170
942
F19.2
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome
21.7
12.0
17
8
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
12.0
372
2679
J01DB01
ATC
cefalexin; oral
1.8
12.0
644
5453
R52.9
ICD-10 Finland
Pain, unspecified
2.9
12.0
77
287
L12
ICPC
Hand/finger symptom/complaint
2.1
11.9
145
756
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.8
11.9
262
1699
L28
ICPC
Limited function/disability (L)
2.9
11.8
73
267
F98.00
ICD-10 Finland
Nonorganic enuresis nocturna
14.9
11.8
19
13
S29
ICPC
Skin symptom/complaint other
2.2
11.8
125
612
R03AC02
ATC
salbutamol; inhalant
1.7
11.7
404
2997
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.2
11.7
62
205
Y04.2
ICD-10 Finland
Assault by bodily force by friend
23.3
11.6
16
7
P28
ICPC
Limited function/disability (P)
8.8
11.6
24
28
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
6.9
11.5
28
42
SPAT1265
SPAT
Breathalyser
7.6
11.5
26
35
R02
ICPC
Shortness of breath/dyspnoea
2.6
11.5
86
354
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.2
11.5
59
191
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
6.5
11.5
29
46
R53
ICD-10 Finland
Malaise and fatigue
2.0
11.5
155
844
A01
ICPC
Pain general/multiple sites
3.0
11.4
65
225
F82
ICD-10 Finland
Specific developmental disorder of motor function
8.5
11.4
24
29
F20.34
ICD-10 Finland
Undifferentiated schizophrenia with partial recurrence
15.3
11.3
18
12
Z72.1
ICD-10 Finland
Alcohol use
6.7
11.3
28
43
Z72.0
ICD-10 Finland
Tobacco use
5.2
11.3
34
67
Z86.4
ICD-10 Finland
Personal history of psychoactive substance abuse
10.7
11.3
21
20
F20.39
ICD-10 Finland
Undifferentiated schizophrenia UNS
9.8
11.3
22
23
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
11.3
132
675
Z64.0
ICD-10 Finland
Problems related to unwanted pregnancy
4.3
11.2
41
100
Z29
ICPC
Social problem NOS
4.8
11.2
36
77
S61.9
ICD-10 Finland
Open wound of wrist and hand, part unspecified
4.2
11.1
42
105
P27
ICPC
Fear of mental disorder
5.7
11.1
31
56
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.5
11.1
94
411
IEP99
NOMESCO Finland
Other psychiatric family intervention
11.4
11.1
20
18
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
8.7
11.1
23
27
N05CF02
ATC
zolpidem; oral
2.2
11.1
118
579
F43.24
ICD-10 Finland
Adaptive disorder with behavioral disorder
43.9
10.9
13
*
E66.01
ICD-10 Finland
Obesity due to excess calories
2.7
10.9
76
300
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.4
10.9
99
451
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
5.0
10.9
34
70
N06AX03
ATC
mianserin; oral
4.7
10.9
36
79
J45.9
ICD-10 Finland
Asthma, unspecified
2.2
10.9
123
619
Z35.7
ICD-10 Finland
Supervision of high-risk pregnancy due to social problems
15.7
10.9
17
11
K04.1
ICD-10 Finland
Necrosis of pulp
2.4
10.8
93
412
F31.8
ICD-10 Finland
Other bipolar affective disorders
4.9
10.8
34
71
Z04.6
ICD-10 Finland
General psychiatric examination, requested by authority
18.1
10.8
16
9
F20.08
ICD-10 Finland
Paranoid schizophrenia other definite
28.4
10.7
14
5
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
4.8
10.7
35
76
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.2
10.7
56
184
RS140
NOMESCO Finland
NA
13.1
10.7
18
14
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
4.3
10.7
39
95
EBA15
NOMESCO Finland
Extraction of large number of teeth
4.9
10.7
34
72
R45.5
ICD-10 Finland
Hostility
60.8
10.6
12
*
R11
ICD-10 Finland
Nausea and vomiting
2.5
10.6
81
338
R05
ICPC
Cough
1.9
10.6
186
1115
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
10.2
10.5
20
20
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
10.2
10.5
20
20
N05AC02
ATC
thioridazine; oral
5.5
10.5
30
56
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
5.7
10.5
29
52
P17
ICPC
Tobacco abuse
6.9
10.4
25
37
F95.2
ICD-10 Finland
Combined vocal and multiple motor tic disorder [de la Tourette]
+∞
10.4
10
*
Z60.9
ICD-10 Finland
Problem related to social environment, unspecified
+∞
10.4
10
*
F19.39
ICD-10 Finland
Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances UNS
+∞
10.4
10
*
Z03
ICPC
Housing/neighbourhood problem
12.2
10.4
18
15
SPAT1283
SPAT
Restricted health certificate
1.7
10.4
256
1708
F22.0
ICD-10 Finland
Delusional disorder
8.3
10.4
22
27
F21
ICD-10 Finland
Schizotypal disorder
8.3
10.4
22
27
F32.8
ICD-10 Finland
Other depressive episodes
5.4
10.4
30
57
30188
ICD-8 Finland
Personality disorders, Alia definita
33.0
10.3
13
*
SPAT1301
SPAT
No procedures
1.7
10.3
239
1561
F81.9
ICD-10 Finland
Developmental disorder of scholastic skills, unspecified
9.7
10.3
20
21
F70.9
ICD-10 Finland
Mild mental retardation, Without mention of impairment of behaviour
23.7
10.3
14
6
A06AD11
ATC
lactulose; oral
2.6
10.2
75
305
N76.0
ICD-10 Finland
Acute vaginitis
2.6
10.2
77
316
SPAT1281
SPAT
Other administrative function
2.5
10.2
78
326
SPAT1275
SPAT
Drug rehabilitation and replacement therapy of opioid-dependent person
8.6
10.1
21
25
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.7
10.0
68
265
F13.1
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
14.8
10.0
16
11
F11.1
ICD-10 Finland
Mental and behavioural disorders due to use of opioids, harmful use
14.8
10.0
16
11
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
14.8
10.0
16
11
2989X
ICD-9 Finland
Other nonorganic psychoses, Unspecified psychosis
14.8
10.0
16
11
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.3
10.0
93
428
XA800
NOMESCO Finland
Neuropsychological investigation
3.2
10.0
51
165
30920
ICD-8 Finland
Mental disorders not specified as psychotic associated with physical conditions, Brain trauma
40.6
10.0
12
*
Z61.2
ICD-10 Finland
Altered pattern of family relationships in childhood
40.6
10.0
12
*
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.2
9.9
108
535
N05AL01
ATC
sulpiride; systemic
10.8
9.8
18
17
F81.3
ICD-10 Finland
Mixed disorder of scholastic skills
9.7
9.8
19
20
N05AD03
ATC
melperone; systemic
9.7
9.8
19
20
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.3
9.8
89
406
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
4.3
9.8
35
84
R06.0
ICD-10 Finland
Dyspnoea
2.0
9.7
133
727
A04
ICPC
Weakness/tiredness general
2.1
9.7
121
636
RS312
NOMESCO Finland
NA
55.7
9.7
11
*
SPAT1227
SPAT
Substance abuse rehabilitation
7.9
9.7
21
27
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
7.9
9.7
21
27
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
8.5
9.6
20
24
F20.04
ICD-10 Finland
Paranoid schizophrenia with partial recurrence
8.5
9.6
20
24
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
10.2
9.5
18
18
T50.9
ICD-10 Finland
Poisoning: Other and unspecified drugs, medicaments and biological substances
10.2
9.5
18
18
F10.22
ICD-10 Finland
Alcohol dependence is currently on clinically controlled discontinuation medication
15.2
9.5
15
10
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
9.5
219
1427
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
2.2
9.5
103
510
9691A
ICD-9 Finland
Poisoning by psychotropic agents, Phenothiazine-based tranquillisers
30.4
9.4
12
*
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.9
9.4
162
960
F11.20
ICD-10 Finland
Addiction-induced dependence caused by opiates currently independent
12.5
9.4
16
13
IGY02
SPAT
NA
8.2
9.4
20
25
F19.30
ICD-10 Finland
Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated
22.0
9.4
13
6
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
4.7
9.3
30
65
M54
ICD-10 Finland
Dorsalgia
2.2
9.3
93
444
F41.09
ICD-10 Finland
UNS Panic Syndrome
3.3
9.2
46
147
F11.24
ICD-10 Finland
Addiction-induced dependence caused by opiates active addiction
8.4
9.1
19
23
F42.1
ICD-10 Finland
Predominantly compulsive acts [obsessional rituals]
8.4
9.1
19
23
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
9.1
180
1117
F05.9
ICD-10 Finland
Delirium, unspecified
7.2
9.1
21
30
N03AF02
ATC
oxcarbazepine; oral
3.6
9.1
39
111
3050A
ICD-9 Finland
Nondependent abuse of drugs, Alcohol abuse
37.1
9.0
11
*
R45.1
ICD-10 Finland
Restlessness and agitation
37.1
9.0
11
*
K08.80
ICD-10 Finland
Toothache NOS
2.6
9.0
67
274
N93.9
ICD-10 Finland
Abnormal uterine and vaginal bleeding, unspecified
5.6
9.0
25
46
A11
ICPC
Chest pain NOS
3.1
8.9
48
163
N05AE04
ATC
ziprasidone; systemic
8.7
8.8
18
21
S10
ICPC
Boil/carbuncle
3.0
8.8
50
173
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
10.9
8.8
16
15
IBZ02
NOMESCO Finland
Somatic assessment of psychiatric patient
10.9
8.8
16
15
F40.1
ICD-10 Finland
Social phobias
3.3
8.8
42
130
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.5
8.7
69
294
A02BC02
ATC
pantoprazole; systemic
1.6
8.7
351
2644
113
Kela drug reimbursment
Anxiety disorders associated with mental retardation
50.5
8.7
10
*
A29
ICPC
General symptom/complaint other
2.3
8.7
79
359
M54.4
ICD-10 Finland
Lumbago with sciatica
2.1
8.7
98
494
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
7.8
8.7
19
25
XF600
NOMESCO Finland
Bloodpressure measurement
2.8
8.7
54
199
E66.9
ICD-10 Finland
Obesity, unspecified
3.7
8.6
36
100
K10.3
ICD-10 Finland
Alveolitis of jaws
2.8
8.6
54
201
F89
ICD-10 Finland
Unspecified disorder of psychological development
16.5
8.6
13
8
N05CD02
ATC
nitrazepam; oral
10.2
8.5
16
16
WX002
NOMESCO Finland
Sedation and analgesia
2.1
8.5
101
519
SPAT1059
SPAT
Spirometry at the office
3.8
8.5
35
96
X58
ICD-10 Finland
Exposure to other specified factors
1.9
8.5
136
782
W01
ICPC
Question of pregnancy
5.5
8.5
24
45
R07
ICPC
Sneezing/nasal congestion
2.2
8.5
90
441
F20
ICD-10 Finland
Schizophrenia
7.5
8.5
19
26
NA1AD
NOMESCO Finland
Cervical spine CT examination
3.4
8.5
40
123
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.1
8.4
102
526
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.8
8.4
173
1083
WX892
NOMESCO Finland
Monitored bed care
2.8
8.4
53
197
3017A
ICD-9 Finland
Personality disorders, Antisocial personality disorder
90.9
8.4
9
*
RS210
NOMESCO Finland
NA
12.9
8.4
14
11
P03
ICPC
Feeling depressed
1.9
8.4
126
709
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
5.3
8.4
24
46
F31
ICD-10 Finland
Bipolar affective disorder
6.3
8.4
21
34
3123A
ICD-9 Finland
Disturbance of conduct not elsewhere classified, Disorders of impulse control, not elsewhere classified[PELIHIMO]
+∞
8.3
8
*
Z72.9
ICD-10 Finland
Problem related to lifestyle, unspecified
+∞
8.3
8
*
3138C
ICD-9 Finland
Disturbance of emotions specific to childhood and adolescence, Other or mixed emotional disturbances of childhood or adolescence[LAPSUUSIÄN RAJATILAHÄIRIÖ]
+∞
8.3
8
*
3141A
ICD-9 Finland
Hyperkinetic syndrome of childhood, Hyperkinesis with developmental delay
+∞
8.3
8
*
3093A
ICD-9 Finland
Adjustment reaction, With predominant disturbance of conduct
+∞
8.3
8
*
W17
ICD-10 Finland
Other fall from one level to another
2.7
8.3
54
206
F63.0
ICD-10 Finland
Pathological gambling
10.9
8.3
15
14
J01AA02
ATC
doxycycline; systemic
1.5
8.3
434
3461
U01
ICPC
Dysuria/painful urination
2.5
8.3
63
263
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.8
8.2
165
1024
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.0
8.2
101
527
F43.25
ICD-10 Finland
Adaptive disorder with mixed mental disorder and behavioral disorder
14.6
8.2
13
9
N06AX26
ATC
vortioxetine; oral
2.6
8.2
59
238
Z04.0
ICD-10 Finland
Blood-alcohol and blood-drug test
11.8
8.1
14
12
F12.24
ICD-10 Finland
Addiction caused by cannabis active addiction
33.7
8.1
10
*
X61
ICD-10 Finland
Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified
33.7
8.1
10
*
K04.7
ICD-10 Finland
Periapical abscess without sinus
2.8
8.1
49
180
188
Kela drug reimbursment
Psychosis requiring demanding treatment
9.0
8.1
16
18
W0A12
NOMESCO Finland
Planned therapy visit for psychiatric disease
9.0
8.1
16
18
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
10.2
8.0
15
15
S51.8
ICD-10 Finland
Open wound of other parts of forearm
6.4
8.0
20
32
R21
ICPC
Throat symptom/complaint
1.6
8.0
254
1792
R4110
NOMESCO Finland
Physiotherapy
1.8
8.0
160
991
SGC10
NOMESCO Finland
Covering pulpa of tooth
2.0
8.0
111
607
M03BC01
ATC
orphenadrine (citrate); systemic
1.8
8.0
155
949
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
2.9
8.0
46
162
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
7.3
8.0
18
25
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
8.0
137
808
LCH00
NOMESCO Finland
Vacuum aspiration of products of conception from uterus
4.3
8.0
28
67
WX872
NOMESCO Finland
Intensive care
3.7
7.9
33
92
KAY40
NOMESCO Finland
NA
0.2
7.9
5
322
TPH07
NOMESCO Finland
Cathetrisation of artery
2.6
7.9
57
229
SPAT1243
SPAT
Psychiatric/psychological examination
2.8
7.9
50
187
N30.0
ICD-10 Finland
Acute cystitis
2.1
7.9
92
468
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
13.2
7.9
13
10
T40.9
ICD-10 Finland
Poisoning: Other and unspecified psychodysleptics [hallucinogens]
13.2
7.9
13
10
KAY20
NOMESCO Finland
NA
0.1
7.9
*
253
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
3.1
7.9
42
142
SPAT1216
SPAT
Assessment of functional ability
2.4
7.8
66
290
RF220
NOMESCO Finland
NA
8.6
7.8
16
19
RS220
NOMESCO Finland
NA
4.9
7.8
24
50
SPAT1310
SPAT
Counselling related to known health issue
1.6
7.8
257
1831
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.9
7.8
113
629
A03
ICPC
Fever
1.7
7.8
195
1293
R4120
NOMESCO Finland
Occupational therapy
2.8
7.8
49
183
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.2
7.7
78
374
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
5.4
7.7
22
42
N05AE05
ATC
lurasidone; oral
15.2
7.7
12
8
F15.3
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, withdrawal state
45.4
7.7
9
*
E9509
ICD-8 Finland
Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances
45.4
7.7
9
*
S51.9
ICD-10 Finland
Open wound of forearm, part unspecified
7.5
7.7
17
23
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
7.7
138
827
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.2
7.6
75
355
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.4
7.6
62
268
G44.2
ICD-10 Finland
Tension-type headache
2.0
7.6
100
533
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.3
7.6
67
300
F40.2
ICD-10 Finland
Specific (isolated) phobias
6.8
7.6
18
27
TKC20
NOMESCO Finland
Catheterisation of bladder
3.5
7.6
34
101
N06AA09
ATC
amitriptyline; systemic
3.0
7.6
43
149
9985A
ICD-9 Finland
Other complications of procedures, not elsewhere classified, Postoperative infection
25.3
7.6
10
*
Y04.0
ICD-10 Finland
Assault by bodily force by spouse or partner
10.1
7.5
14
14
F10.23
ICD-10 Finland
Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication
10.1
7.5
14
14
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
10.1
7.5
14
14
T65.9
ICD-10 Finland
Toxic effect: Toxic effect of unspecified substance
10.1
7.5
14
14
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
2.1
7.5
81
399
N71.0
ICD-10 Finland
Acute inflammatory disease of uterus
3.8
7.5
30
81
N05AX13
ATC
paliperidone; systemic
7.2
7.5
17
24
N06AX05
ATC
trazodone; oral
4.5
7.5
25
57
U02
ICPC
Urinary frequency/urgency
2.1
7.5
87
442
A10BA02
ATC
metformin; oral
2.0
7.5
101
545
R00.2
ICD-10 Finland
Palpitations
2.5
7.5
55
226
-50
ICPC
Medication/prescr/renewal
3.6
7.5
32
92
78020
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Convulsions
6.5
7.4
18
28
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.8
7.4
121
702
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.6
7.4
52
208
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.9
7.4
117
668
F93.1
ICD-10 Finland
Phobic anxiety disorder of childhood
80.8
7.4
8
*
F34.9
ICD-10 Finland
Persistent mood [affective] disorder, unspecified
13.5
7.4
12
9
R44.0
ICD-10 Finland
Auditory hallucinations
13.5
7.4
12
9
IAB08
NOMESCO Finland
Consultation concerning a patient who has attempted suicide
13.5
7.4
12
9
F11.30
ICD-10 Finland
Withdrawal symptoms caused by opiates uncomplicated
13.5
7.4
12
9
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.0
7.4
42
146
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.6
7.4
250
1788
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
7.4
443
3602
K04.09
ICD-10 Finland
Pulpit UNS
2.7
7.3
48
185
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
2.5
7.3
54
222
M79.1
ICD-10 Finland
Myalgia
2.0
7.3
92
487
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
2.4
7.3
62
274
SPAT1229
SPAT
Assessment of need for aid
3.3
7.3
34
105
F43.00
ICD-10 Finland
Acute stress reaction mild
3.6
7.3
31
89
Z00.8
ICD-10 Finland
Other general examinations
2.2
7.2
72
342
T00.9
ICD-10 Finland
Multiple superficial injuries, unspecified
15.9
7.2
11
7
F60.0
ICD-10 Finland
Paranoid personality disorder
15.9
7.2
11
7
E66.8
ICD-10 Finland
Other obesity
3.0
7.2
41
143
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.7
7.2
178
1173
A02BC01
ATC
omeprazole; systemic
1.8
7.2
140
859
SPAT1260
SPAT
Consultation of another employee
1.8
7.2
120
700
78159
ICD-8 Finland
Other symptoms referable to nervous system and special senses, Laesio loquendi alia sive NUD
30.3
7.2
9
*
3092E
ICD-9 Finland
Adjustment reaction, With predominant disturbance of other emotions[USEINA EMOTIONAALISINA OIREINA ILM.SOPEUTUMISHÄIRIÖ]
30.3
7.2
9
*
XA820
NOMESCO Finland
NA
20.2
7.1
10
5
Y07
ICD-10 Finland
Other maltreatment
6.7
7.1
17
26
R33
ICD-10 Finland
Retention of urine
3.8
7.1
28
75
OAB43
SPAT
NA
0.5
7.1
75
1301
F25.20
ICD-10 Finland
Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms
12.2
7.1
12
10
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.5
7.1
52
212
F32.1
ICD-10 Finland
Moderate depressive episode
2.3
7.1
66
305
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.8
7.1
42
153
R60.0
ICD-10 Finland
Localized oedema
2.6
7.0
47
184
L01
ICPC
Neck symptom/complaint
1.9
7.0
100
554
N05CD08
ATC
midazolam; nasal, systemic
5.0
7.0
21
43
K05.31
ICD-10 Finland
Periodontitis pronounced
2.7
7.0
46
178
R07.3
ICD-10 Finland
Other chest pain
2.5
7.0
52
215
A05
ICPC
Feeling ill
1.9
7.0
105
593
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
5.5
6.9
19
35
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
5.5
6.9
19
35
Y94.0
ICD-10 Finland
Accident at home
7.6
6.9
15
20
N05AB01
ATC
dixyrazine; systemic
13.9
6.9
11
8
R74
ICPC
Upper respiratory infection acute
1.5
6.9
308
2339
K02.9
ICD-10 Finland
Dental caries, unspecified
4.2
6.8
24
58
F40.9
ICD-10 Finland
Phobic anxiety disorder, unspecified
8.4
6.8
14
17
Z63.4
ICD-10 Finland
Disappearance and death of family member
8.4
6.8
14
17
R50.9
ICD-10 Finland
Fever, unspecified
1.8
6.8
114
664
9694A
ICD-9 Finland
Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers
11.0
6.8
12
11
R06.4
ICD-10 Finland
Hyperventilation
4.6
6.8
22
49
ICC03
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric ward
9.4
6.8
13
14
P98
ICPC
Psychosis NOS/other
5.7
6.8
18
32
IBA02
NOMESCO Finland
Evaluation of need for psychiatric rehabilitation
5.7
6.8
18
32
W79
ICPC
Unwanted pregnancy
3.5
6.8
30
89
WX290
SPAT
NA
3.2
6.8
34
111
T42.4
ICD-10 Finland
Poisoning: Benzodiazepines
40.4
6.8
8
*
Z62.0
ICD-10 Finland
Inadequate parental supervision and control
40.4
6.8
8
*
F19.22
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but using substitute intermittent medication
40.4
6.8
8
*
F11.9
ICD-10 Finland
Mental and behavioural disorders due to use of opioids, unspecified mental and behavioural disorder
40.4
6.8
8
*
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.9
6.8
101
566
Z61.7
ICD-10 Finland
Personal frightening experience in childhood
16.8
6.8
10
6
IFC01
NOMESCO Finland
Withdrawal and replacement therapy for opioid addiction
16.8
6.8
10
6
F05.8
ICD-10 Finland
Other delirium
16.8
6.8
10
6
Z32.1
ICD-10 Finland
Pregnancy confirmed
1.9
6.7
103
584
F32
ICD-10 Finland
Depressive episode
2.4
6.7
56
246
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
4.5
6.7
22
50
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.7
6.7
44
171
A99
ICPC
Disease/condition unspecnature/site
2.4
6.7
53
227
SPAT1263
SPAT
Sampling
1.5
6.7
330
2555
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.1
6.7
73
364
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.5
6.7
29
85
N06DX01
ATC
memantine; oral
6.5
6.7
16
25
R32
ICD-10 Finland
Unspecified urinary incontinence
6.0
6.6
17
29
P80
ICPC
Personality disorder
7.9
6.6
14
18
N03AX14
ATC
levetiracetam; systemic
3.7
6.6
27
75
Z09
ICPC
Legal problem
12.4
6.6
11
9
K59.0
ICD-10 Finland
Constipation
3.0
6.6
36
125
N92.1
ICD-10 Finland
Excessive and frequent menstruation with irregular cycle
2.8
6.6
39
142
F23.99
ICD-10 Finland
Acute and transient psychosis, unspecified UNS
8.8
6.6
13
15
P22
ICPC
Child behaviour symptom/complaint
4.9
6.6
20
42
S63.5
ICD-10 Finland
Sprain and strain of wrist
2.7
6.6
42
159
RS120
NOMESCO Finland
NA
10.1
6.5
12
12
IER01
NOMESCO Finland
Psychoeducation, group
6.9
6.5
15
22
T82
ICPC
Obesity
3.2
6.5
32
103
X23
ICPC
Fear sexually transm dis female
2.0
6.5
82
433
V03AA01
ATC
NA
6.3
6.5
16
26
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
5.8
6.5
17
30
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.0
6.5
82
435
R73.9
ICD-10 Finland
Hyperglycaemia, unspecified
4.7
6.4
20
43
3041A
ICD-9 Finland
Drug dependence, Barbiturate and similarly acting sedative or hypnotic dependence
70.4
6.4
7
*
3159X
ICD-9 Finland
Specific delays in development, Unspecified delay in development
70.4
6.4
7
*
R4170
NOMESCO Finland
Therapy forms involving educational rehabilitation
70.4
6.4
7
*
F19.53
ICD-10 Finland
Psychotic disorder caused by several drugs in combination and by other psychoactive substances polymorphic
70.4
6.4
7
*
Z62.8
ICD-10 Finland
Other specified problems related to upbringing
70.4
6.4
7
*
30199
ICD-8 Finland
Personality disorders, Unspecified
70.4
6.4
7
*
Z62.2
ICD-10 Finland
Institutional upbringing
70.4
6.4
7
*
30170
ICD-8 Finland
Personality disorders, Antisocial
70.4
6.4
7
*
F63.8
ICD-10 Finland
Other habit and impulse disorders
70.4
6.4
7
*
F12.09
ICD-10 Finland
Intoxication caused by cannabis UNS
70.4
6.4
7
*
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.4
6.4
54
237
F12.29
ICD-10 Finland
Addiction caused by cannabis UNS
14.4
6.4
10
7
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
6.6
6.4
15
23
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
6.6
6.4
15
23
D09
ICPC
Nausea
2.1
6.3
69
345
Y04.9
ICD-10 Finland
Assault by bodily force by unknown person
4.0
6.3
23
58
Z25
ICPC
Assault/harmful event problem
4.6
6.3
20
44
D06
ICPC
Abdominal pain localized other
2.1
6.3
66
323
30000
ICD-8 Finland
Neuroses, Anxiety neurosis
11.1
6.3
11
10
F20.8
ICD-10 Finland
Other schizophrenia
9.3
6.3
12
13
F31.5
ICD-10 Finland
Bipolar affective disorder, current episode severe depression with psychotic symptoms
9.3
6.3
12
13
F11.26
ICD-10 Finland
Addiction caused by opiates intermittent drug addiction
+∞
6.3
6
*
T40.7
ICD-10 Finland
Poisoning: Cannabis (derivatives)
+∞
6.3
6
*
B86
ICD-10 Finland
Scabies
3.3
6.2
29
90
F43.29
ICD-10 Finland
Adaptation disorder UNS
3.6
6.2
26
74
F10.52
ICD-10 Finland
Psychotic alcohol hallucination
26.9
6.2
8
*
RS313
NOMESCO Finland
NA
26.9
6.2
8
*
2971A
ICD-9 Finland
Paranoid states, Paranoia
26.9
6.2
8
*
Z61.1
ICD-10 Finland
Removal from home in childhood
26.9
6.2
8
*
L84
ICD-10 Finland
Corns and callosities
4.0
6.2
23
59
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
5.1
6.2
18
36
EBA30
NOMESCO Finland
Excision of root of tooth
3.0
6.2
33
113
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
3.0
6.2
33
113
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
6.3
6.2
15
24
R25.1
ICD-10 Finland
Tremor, unspecified
5.8
6.2
16
28
K03.66
ICD-10 Finland
Tooth plaque
2.1
6.2
69
346
K92.0
ICD-10 Finland
Haematemesis
4.3
6.1
21
50
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.2
6.1
58
272
Z27
ICPC
Fear of a social problem
7.7
6.1
13
17
N06AX22
ATC
agomelatine; oral
3.8
6.1
24
65
J20
ICD-10 Finland
Acute bronchitis
2.2
6.1
60
286
F40.01
ICD-10 Finland
Agoraphobia with concomitant panic disorder
6.8
6.1
14
21
WVA20
SPAT
NA
6.8
6.1
14
21
Z35.6
ICD-10 Finland
Supervision of very young primigravida
10.1
6.0
11
11
IBZ06
NOMESCO Finland
Evaluation concerning developmental neuropsychiatry
10.1
6.0
11
11
183
Kela drug reimbursment
Lamotrigin and topiramate
5.2
6.0
17
33
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.7
6.0
39
149
S06
ICPC
Rash localized
2.5
6.0
43
175
N06AX21
ATC
duloxetine; oral
2.1
6.0
64
316
W25
ICD-10 Finland
Contact with sharp glass
4.6
6.0
19
42
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3028707) Methadone [Presence] in Urine by Screen method
199
321
7.66
123.37
5.8
3.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
230
564
5.12
90.37
8.7
3.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
240
682
4.42
77.46
5.5
2.2
—
—
—
0
0
(4198724)
80
78
11.15
73.05
3.4
2.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
252
829
3.82
65.32
5.5
2.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
256
893
3.60
60.26
5.5
2.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
312
1243
3.30
59.23
2.4
1.8
%
1.6
1.4
7.92
274
1136
(3028300) Cannabinoids [Presence] in Urine
255
902
3.54
58.57
5.5
2.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
254
900
3.53
58.14
5.5
2.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
249
891
3.47
55.89
5.3
2.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
55
51
11.41
51.71
2.2
1.8
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
342
1548
2.94
50.63
5.8
3.6
mmol/l
8.9
8.9
0.03
309
1375
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
51
45
11.95
49.50
1.8
1.7
iu/ml
440333.3
871730.0
—
6
5
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
422
2187
2.74
47.56
4.1
3.3
u/l
35.5
31.9
0.86
406
2092
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
655
4370
2.79
42.31
7.1
6.4
u/l
81.3
78.0
0.95
625
4123
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
473
2731
2.53
40.86
5.1
5.5
umol/l
9.9
11.2
1.23
441
2561
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
394
2135
2.49
38.43
7.2
6.8
mmol/l
1.2
1.2
0.35
368
1970
(3013826) Glucose [Moles/volume] in Serum or Plasma
540
3376
2.48
38.35
6.2
4.6
mmol/l
6.5
6.3
0.71
503
3027
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
416
2372
2.39
35.51
7.5
7.2
mmol/l
1.2
1.2
0.54
373
2040
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
34
29
12.14
33.56
6.3
2.7
umol/l
182.9
186.5
0.01
14
15
(3013650) Neutrophils [#/volume] in Blood by Automated count
577
3866
2.35
32.89
15.8
8.8
e9/l
4.4
3.9
5.86
506
3366
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
711
5237
2.64
32.61
4.6
3.6
pmol/l
14.5
14.5
0.02
671
4817
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
272
1327
2.50
32.30
2.9
2.0
u/l
354.0
294.6
0.27
256
1268
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
25
13
19.75
31.92
1.3
1.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
321
1722
2.34
30.53
1.7
1.6
pmol/l
99.1
98.3
0.10
191
950
(3023103) Potassium [Moles/volume] in Serum or Plasma
819
6570
3.49
30.51
16.6
9.6
mmol/l
3.9
3.9
0.00
805
6336
(3019550) Sodium [Moles/volume] in Serum or Plasma
817
6545
3.45
30.50
16.8
9.6
mmol/l
139.5
139.5
0.14
805
6331
(40758558) Short blood count panel - Blood
302
1635
2.27
27.60
9.7
6.9
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
144
549
2.93
27.54
3.8
6.1
kpa
6.1
5.9
2.18
137
534
(3002032) Base excess in Venous blood by calculation
143
546
2.92
27.26
4.0
6.2
mmol/l
1.9
1.6
0.51
119
439
(3019150) Specific gravity of Urine by Refractometry
277
1454
2.30
27.20
4.9
3.0
kg/l
1.0
1.0
0.06
37
204
(3013115) Eosinophils [#/volume] in Blood
521
3531
2.11
26.37
11.2
6.9
e9/l
0.2
0.2
0.02
459
3150
(3023368) Bacteria identified in Blood by Culture
240
1203
2.35
26.10
4.4
4.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
773
6162
2.70
26.08
5.7
4.1
mu/l
1.8
2.0
0.51
742
5816
(3015377) Calcium [Moles/volume] in Serum or Plasma
289
1568
2.24
26.02
2.4
2.9
mmol/l
2.4
2.4
0.40
256
1422
(3006315) Basophils [#/volume] in Blood
508
3425
2.10
25.89
9.4
6.6
e9/l
0.0
0.0
0.89
438
2999
(3001604) Monocytes [#/volume] in Blood
507
3419
2.09
25.79
9.5
6.5
e9/l
0.6
0.5
4.86
438
2992
(3023511) Choriogonadotropin [Units/volume] in Urine
110
373
3.22
25.72
1.7
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
76
206
3.93
24.96
1.6
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
268
1437
2.23
24.63
2.2
1.7
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
345
2059
2.09
23.94
4.0
5.3
g/l
36.7
37.7
2.18
322
1938
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
297
1683
2.14
23.57
3.9
2.6
u/l
55.8
57.2
0.11
281
1578
(3019309) Folate [Moles/volume] in Red Blood Cells
147
614
2.66
23.45
1.7
1.6
nmol/l
1116.7
1146.0
0.14
113
490
(3042517) Benzodiazepines panel - Urine
21
15
14.31
22.84
3.3
2.9
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
111
407
2.97
22.61
9.1
9.5
mmol/l
1.3
0.5
1.32
86
332
(3018418) pH of Serum or Plasma
250
1343
2.19
22.60
4.0
4.0
ph
7.4
7.4
0.76
38
258
(3026008) Bacteria identified in Urine by Culture
268
1483
2.14
22.44
3.2
2.2
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
41
73
5.83
22.27
2.0
1.2
promille
1.2
1.4
0.32
32
58
(3016502) Oxygen saturation in Arterial blood
103
365
3.05
22.27
9.2
10.1
%
95.4
96.4
0.62
97
352
(42870588) Differential panel, method unspecified - Blood
360
2231
2.02
22.13
8.1
6.7
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
513
3595
1.98
22.08
9.5
6.4
e9/l
2.4
2.0
0.93
449
3208
(3019069) Monocytes/100 leukocytes in Blood
479
3288
1.97
21.81
10.1
6.7
%
7.9
8.2
1.51
452
3133
(3022096) Basophils/100 leukocytes in Blood
462
3136
1.96
21.70
9.6
6.6
%
0.6
0.7
1.72
436
2972
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
181
866
2.36
21.49
3.5
2.8
ng/l
97.3
875.2
2.73
103
495
(3024354) Oxygen [Partial pressure] in Venous blood
121
478
2.77
21.44
3.2
6.0
kpa
4.9
4.9
0.10
115
466
(3014111) Lactate [Moles/volume] in Serum or Plasma
115
445
2.81
21.18
8.0
7.2
mmol/l
1.4
1.4
0.31
108
425
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
124
503
2.70
20.85
1.9
1.7
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
472
3259
1.93
20.75
9.6
6.5
%
2.6
2.8
1.75
446
3080
(3044889) 12 lead EKG panel
517
3689
1.93
20.48
3.3
2.6
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
95
339
3.01
20.25
9.7
10.6
g/l
128.2
126.6
0.30
90
322
(3027801) Oxygen [Partial pressure] in Arterial blood
107
412
2.81
19.86
9.2
9.3
kpa
11.6
13.9
5.69
99
396
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
123
509
2.64
19.85
1.9
1.7
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
107
413
2.80
19.77
9.3
9.3
kpa
5.3
5.1
1.16
99
394
(3018010) Neutrophils/100 leukocytes in Blood
483
3408
1.89
19.40
9.5
6.2
%
55.4
55.1
0.16
455
3251
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
159
750
2.36
19.37
2.0
1.8
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
84
287
3.12
19.29
1.5
1.4
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
66
194
3.59
19.25
7.4
10.7
mmol/l
24.7
24.4
0.20
60
178
(3021960) Folate [Moles/volume] in Serum or Plasma
183
921
2.24
19.11
1.6
1.4
nmol/l
16.6
20.1
3.72
169
812
(3000991) Gas panel - Venous blood
121
508
2.59
18.93
8.7
8.9
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
48
115
4.35
18.56
3.5
1.8
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
334
2127
1.90
18.12
4.2
3.5
e6/l
53.3
70.8
0.32
228
1388
(3002030) Lymphocytes/100 leukocytes in Blood
483
3462
1.84
17.93
9.9
6.4
%
30.8
30.8
0.03
454
3298
(3033658) Prothrombin time (PT) actual/Normal
251
1463
1.99
17.63
4.1
4.3
%
93.2
92.5
0.17
241
1430
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
308
1931
1.90
17.38
3.6
3.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
718
5879
2.05
17.28
4.3
2.9
mmol/l
5.9
5.6
4.89
679
5485
(3007853) Bacteria identified in Skin by Aerobe culture
152
746
2.25
16.72
1.9
1.6
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
121
541
2.43
16.49
8.2
7.5
mmol/l
104.1
104.3
0.22
115
530
(3032080) INR in Blood by Coagulation assay
279
1721
1.90
16.38
5.7
5.4
inr
1.1
1.1
0.59
92
586
(3031040) Bacteria [#/volume] in Urine by Automated count
543
4120
1.79
15.87
5.6
3.6
e6/l
2500.5
1163.8
0.21
12
53
(3002582) Erythrocytes [#/volume] in Urine
274
1697
1.88
15.79
3.4
3.1
e6/l
40.5
109.5
0.86
216
1275
(3021589) Normoblasts [#/volume] in Blood
434
3090
1.77
15.76
9.9
8.4
e9/l
0.0
0.0
1.27
340
2488
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
266
1645
1.87
15.33
3.4
2.6
ng/l
27.9
37.1
0.33
147
748
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
637
5099
1.83
15.23
4.6
2.9
u/l
47.5
36.0
3.00
606
4907
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
360
2446
1.78
15.20
2.4
2.4
nmol/l
63.8
69.9
3.74
338
2298
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
114
519
2.37
14.88
2.8
1.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
247
1527
1.85
14.07
3.5
3.0
e6/l
0.3
0.3
0.31
189
1121
(3021879) Hepatitis B virus core Ab [Presence] in Serum
167
906
2.03
14.04
1.8
1.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
233
1417
1.87
13.97
3.6
2.9
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
583
4608
1.74
13.87
3.6
3.5
mm/h
9.0
8.0
1.50
540
4304
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
60
210
2.99
13.20
11.4
12.1
—
—
—
0
0
(3026782) Osmolality of Urine
189
1095
1.92
13.07
2.7
2.5
mosm/kgh2o
520.9
578.8
2.21
168
946
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
334
2299
1.72
12.98
2.2
1.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
137
715
2.08
12.73
2.3
2.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
195
1152
1.88
12.67
2.9
2.7
e6/l
9.3
7.3
0.80
174
1016
(36304419) Bacteria [Presence] in Urine
245
1559
1.78
12.48
3.4
2.9
—
—
—
0
0
(3019060) Gas panel - Arterial blood
58
207
2.92
12.33
5.5
7.6
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
86
375
2.43
12.32
4.0
6.7
mmol/l
24.1
23.9
0.39
80
357
(3037467) Urinalysis macro (dipstick) panel - Urine
565
4504
1.67
12.27
4.8
3.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
712
6048
1.82
12.24
12.7
7.8
ml/min/173m2
104.8
99.5
7.69
556
4703
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
89
397
2.38
12.12
3.8
5.5
kpa
5.3
5.1
1.37
82
375
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
90
404
2.36
12.09
1.6
1.4
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
15
17
8.95
12.03
3.9
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
152
843
1.96
11.89
2.9
2.7
e6/l
5.9
2.8
1.92
79
434
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
155
866
1.95
11.86
3.0
2.6
e6/l
1.6
0.8
1.34
78
455
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
828
7424
2.29
11.85
11.2
7.6
u/l
31.4
28.9
1.63
814
7189
(3009343) pH of Capillary blood
88
395
2.36
11.82
3.5
5.5
ph
7.4
7.4
—
8
40
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
42
127
3.42
11.76
2.9
2.4
ug/l
226.0
281.6
0.23
37
121
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
98
462
2.26
11.74
4.3
2.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
152
848
1.95
11.67
1.7
1.5
pmol/l
420.8
27500431.9
1.08
132
760
(46235355) HIV 1 and 2 tests - Meaningful Use set
401
2960
1.63
11.57
3.0
2.2
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
43
135
3.29
11.36
4.6
8.7
%
0.9
0.9
0.09
38
124
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
60
230
2.72
11.19
1.8
1.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
136
743
1.98
11.07
3.4
2.4
u/l
4634.9
6004.9
0.21
47
308
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
66
270
2.56
10.82
1.4
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
319
2253
1.64
10.80
3.4
2.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
54
1264
0.39
10.73
1.1
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
53
197
2.80
10.48
1.7
1.6
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
42
137
3.17
10.44
4.6
8.6
%
2.6
1.6
2.75
37
124
(3022217) INR in Platelet poor plasma by Coagulation assay
82
377
2.29
10.42
6.6
15.0
inr
1.1
1.2
0.49
17
73
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
210
1341
1.74
10.33
2.4
2.1
mg/l
0.8
0.9
0.26
153
929
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
218
1409
1.72
10.27
2.2
2.2
mg/l
2.7
2.6
0.23
194
1205
(3012095) Magnesium [Moles/volume] in Serum or Plasma
139
788
1.90
10.11
3.0
5.2
mmol/l
0.8
0.8
0.12
119
749
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
17
28
6.17
9.95
2.1
2.1
umol/l
13.4
18.2
0.65
17
28
(3000494) Fungus identified in Specimen by Culture
123
673
1.96
9.93
1.6
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
338
2460
1.60
9.93
3.7
2.4
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
15
9
16.92
9.89
10.6
12.0
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
106
554
2.03
9.74
3.1
2.3
u/l
25.2
37.8
2.54
89
468
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
800
7189
1.94
9.68
16.2
9.6
mg/l
20.8
21.1
0.07
668
5355
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
123
679
1.94
9.67
1.9
2.4
mmol/l
2.4
2.4
0.58
98
586
(3003458) Phosphate [Moles/volume] in Serum or Plasma
125
694
1.93
9.66
6.1
8.3
mmol/l
1.1
1.1
0.66
113
655
(3020682) Albumin/Creatinine [Ratio] in Urine
171
1051
1.77
9.55
4.4
4.5
mg/mmol
23.7
11.8
0.68
120
746
(3027945) Reticulocytes/100 erythrocytes in Blood
96
490
2.07
9.40
4.7
5.0
%
1.7
1.6
0.31
86
452
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
626
5285
1.59
9.35
5.4
3.7
mmol/mol
38.3
37.4
1.07
591
5035
(3012516) Albumin [Mass/volume] in Urine
163
996
1.78
9.27
3.8
3.6
mg/l
518.6
202.9
0.38
121
711
(3020779) Urea [Moles/volume] in Serum or Plasma
93
472
2.08
9.24
9.0
9.6
mmol/l
6.8
6.6
0.10
88
459
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
81
390
2.18
9.21
3.2
5.5
mmol/l
1.2
1.3
0.05
53
278
(3002385) Erythrocyte distribution width [Ratio]
731
6429
1.70
9.08
22.7
11.9
%
13.4
13.2
3.84
722
6290
(3043409) Potassium [Moles/volume] in Arterial blood
31
94
3.38
8.68
4.9
5.5
mmol/l
3.8
3.8
0.13
25
88
(3035350) Ketones [Presence] in Urine by Test strip
419
3282
1.51
8.47
3.8
2.9
estimate
0.0
0.0
0.80
71
658
(3009261) Glucose [Presence] in Urine by Test strip
421
3308
1.51
8.34
3.9
2.9
estimate
0.0
0.0
0.00
75
653
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
59
262
2.34
8.14
2.7
2.0
ug/l
6.9
9.1
0.52
53
235
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
379
2934
1.50
7.96
3.9
4.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
414
3278
1.48
7.70
5.2
4.0
estimate
0.0
0.0
0.50
77
684
(3020891) Body temperature
39
149
2.69
7.38
5.9
6.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
39
149
2.69
7.38
2.8
3.6
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
50
218
2.37
7.21
13.2
9.8
mmol/l
24.7
24.1
0.79
45
208
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
129
792
1.73
7.14
3.3
3.6
ng/l
803.5
1010.9
0.26
103
626
(3013512) EKG study
170
1130
1.62
6.96
3.2
2.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
256
1873
1.51
6.85
2.3
2.3
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
43
180
2.46
6.79
1.3
1.8
e6/l
31.3
13.7
0.50
34
138
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
43
180
2.46
6.79
1.3
1.9
e6/l
84986.2
558.0
0.49
35
144
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
39
156
2.57
6.76
1.4
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
68
347
2.04
6.68
3.3
2.9
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
20
55
3.70
6.50
1.0
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
25
80
3.19
6.48
1.1
1.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
92
526
1.83
6.47
2.0
1.5
mu/l
423.7
287.4
1.86
80
468
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
67
345
2.02
6.43
1.6
1.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
89
505
1.85
6.42
7.3
4.9
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
237
1729
1.50
6.37
3.9
3.1
estimate
0.0
0.0
1.08
75
665
(3024928) Oxygen saturation in Venous blood
29
103
2.88
6.31
3.4
6.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
40
169
2.43
6.21
1.3
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
198
1399
1.53
6.17
3.0
2.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
40
170
2.42
6.13
1.3
1.9
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
118
744
1.67
5.91
3.0
2.8
s
29.2
30.0
0.88
113
729
(3023520) Reticulocytes [#/volume] in Blood
63
328
1.99
5.88
2.9
3.9
e9/l
74.3
71.3
0.23
43
221
(1761868) Lipid panel - Serum or Plasma
203
2724
0.67
5.77
2.4
2.1
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
19
55
3.51
5.75
2.8
3.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
817
7616
1.72
5.74
14.9
8.5
—
—
—
0
0
(3019977) pH of Arterial blood
10
17
5.94
5.63
3.0
6.2
—
7.4
—
0
5
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
200
1443
1.49
5.60
2.3
2.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
49
239
2.11
5.46
1.7
2.7
g/l
66.6
67.9
0.47
40
224
(3016018) Differential panel - Cerebral spinal fluid
22
73
3.06
5.40
1.4
1.9
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
193
1394
1.49
5.36
1.6
1.7
mmol/l
1.6
1.4
1.66
177
1251
(3021901) Oxygen saturation in Capillary blood
24
85
2.87
5.28
2.5
6.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
24
86
2.84
5.17
1.3
2.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
32
695
0.44
5.17
1.2
1.3
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
48
239
2.06
5.09
4.6
6.5
kpa
9.0
9.6
1.02
43
224
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
55
981
0.53
5.00
1.4
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
698
6344
1.43
4.90
4.0
3.2
mmol/l
2.8
2.9
1.92
653
6010
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
10
9.08
4.79
3.0
3.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
10
9.08
4.79
3.0
3.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
20
68
2.98
4.73
1.2
1.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
78
470
1.72
4.63
7.5
4.8
%
0.7
0.8
0.15
30
130
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
160
1144
1.48
4.63
2.8
2.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
320
2594
1.36
4.53
2.1
1.7
—
—
—
0
0
(4027681)
19
66
2.92
4.35
1.4
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
692
6328
1.39
4.30
3.7
3.1
mmol/l
4.5
4.7
4.76
653
6043
(3004588) Protein electrophoresis panel - Serum or Plasma
35
166
2.15
4.24
1.6
2.0
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
108
733
1.54
4.00
2.7
2.4
g/l
2.5
2.5
0.41
93
679
(3007463) Buprenorphine [Presence] in Urine
9
14
6.48
3.99
4.1
3.6
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
12
33
3.67
3.93
1.4
1.4
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
22
88
2.54
3.90
1.1
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
19
71
2.71
3.84
1.1
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
42
222
1.94
3.83
1.3
1.1
—
—
—
0
0
(3019225) pH of Specimen
64
386
1.71
3.82
4.7
4.0
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
6
5
12.07
3.76
4.8
1.0
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
6
5
12.07
3.76
4.8
1.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
312
2577
1.32
3.75
3.8
2.8
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
42
224
1.92
3.74
1.3
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
77
491
1.62
3.73
1.4
1.3
miu/ml
194.1
239.7
0.42
19
244
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
53
306
1.78
3.69
4.4
5.8
ng/l
103.3
72.4
0.83
47
295
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
22
92
2.43
3.58
1.1
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
42
228
1.88
3.56
1.3
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
128
924
1.45
3.52
1.3
1.4
titre
435.6
421.6
—
9
152
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
20
81
2.50
3.48
1.3
1.1
mg/l
123.0
39.1
0.42
14
60
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
48
275
1.79
3.44
1.4
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
15
53
2.86
3.37
1.2
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
14
48
2.95
3.31
1.0
1.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
96
664
1.50
3.28
2.8
2.5
%
22.9
25.6
0.97
79
589
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
19
78
2.47
3.23
1.1
1.1
mg/l
921.3
248.9
0.47
13
62
(3005719) IgG [Mass/volume] in Serum or Plasma
80
534
1.55
3.22
1.8
2.9
g/l
9.7
10.3
0.84
70
489
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
25
117
2.17
3.18
1.2
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
25
117
2.17
3.18
1.2
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
653
6019
1.30
3.16
3.4
2.9
mmol/l
1.4
1.3
5.22
612
5731
(3002179) Metamyelocytes/100 leukocytes in Blood
68
440
1.59
3.14
6.4
4.4
%
0.5
0.5
0.00
17
96
(3010421) pH of Blood
29
145
2.03
3.13
6.1
4.4
ph
7.4
7.4
0.41
24
126
(3013247) Albumin in CSF/Albumin in Serum or Plasma
9
20
4.53
3.12
1.1
1.1
mg/g
28.1
6.7
—
9
20
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
9
20
4.53
3.12
1.1
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
107
765
1.45
3.10
1.2
1.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
98
691
1.47
3.05
2.3
3.5
umol/l
4.2
7.1
3.60
81
581
(3028271) Lactate [Moles/volume] in Capillary blood
17
68
2.53
3.05
2.1
1.9
mmol/l
1.6
1.8
0.44
17
68
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
10
29
3.48
3.05
1.3
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
31
161
1.96
3.03
1.7
1.5
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
7
12
5.87
3.02
1.0
1.0
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
55
341
1.65
3.01
3.7
3.8
mmol/l
1.2
1.2
0.24
47
298
(3036180) Methadone [Presence] in Urine
5
5
10.04
2.98
1.6
2.8
—
—
—
0
0
(3022313) Gas panel - Capillary blood
51
311
1.68
2.98
4.0
5.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
69
454
1.56
2.97
8.1
4.8
%
0.0
0.1
2.37
24
121
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
70
463
1.55
2.95
2.4
2.8
g/l
0.2
0.2
0.42
59
434
(1616796) Gas panel - Central venous blood
26
129
2.05
2.88
5.7
3.4
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
6
9
6.70
2.87
1.0
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
9
6.70
2.87
1.0
1.1
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
8
18
4.47
2.80
1.0
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
676
6297
1.29
2.79
3.7
3.0
mmol/l
1.3
1.4
14.71
635
5993
(40767503) Oxygen content in Capillary blood by calculation
21
97
2.19
2.78
2.7
2.5
%
17.4
17.6
0.10
12
48
(3007461) Platelets [#/volume] in Blood
865
8382
1.66
2.78
27.4
13.7
e9/l
261.9
257.0
1.32
849
8161
(3036481) Cortisol [Moles/volume] in Serum or Plasma
86
608
1.46
2.67
2.1
2.1
nmol/l
360.7
379.2
0.47
81
563
(3025159) Blasts/100 leukocytes in Blood
65
434
1.54
2.65
8.4
4.9
%
0.0
0.1
0.79
19
107
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
136
1044
1.36
2.63
1.3
1.2
iu/ml
52.3
21.3
0.58
35
296
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
25
127
2.00
2.62
1.2
1.3
—
—
—
0
0
(3012501) Base excess in Blood by calculation
25
127
2.00
2.62
6.3
4.6
mmol/l
2.2
2.4
0.13
18
75
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
25
127
2.00
2.62
1.4
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
93
2.18
2.62
1.3
2.0
g/l
3.3
3.1
0.27
12
79
(3035941) MCH [Entitic mass]
865
8394
1.63
2.61
27.2
13.6
pg
30.0
29.9
0.52
856
8304
(3022621) pH of Urine by Test strip
56
363
1.58
2.60
4.3
2.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
7
15
4.69
2.60
1.0
2.4
—
—
—
0
0
(3024731) MCV [Entitic volume]
865
8395
1.63
2.59
27.2
13.6
fl
89.4
89.0
1.77
856
8306
(3026361) Erythrocytes [#/volume] in Blood
865
8396
1.62
2.58
27.3
13.7
e12/l
4.6
4.7
1.97
848
8172
(3019832) Treponema pallidum Ab [Presence] in Serum
237
1972
1.27
2.56
2.3
1.9
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
107
795
1.39
2.53
2.7
2.4
umol/l
13.1
15.3
2.16
98
740
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
18
82
2.22
2.48
1.7
1.5
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
865
8403
1.61
2.48
27.5
13.8
g/l
138.1
139.1
1.39
856
8310
(3010813) Leukocytes [#/volume] in Blood
865
8403
1.61
2.48
27.4
13.7
e9/l
7.5
6.7
7.54
847
8176
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
7
16
4.40
2.48
2.0
4.3
mmol/l
1.2
1.2
—
7
16
(3042111) Morphology [Interpretation] in Bone marrow Narrative
12
45
2.69
2.46
1.2
1.9
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
209
1722
1.28
2.43
7.6
4.3
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
64
436
1.50
2.40
3.4
3.4
pmol/l
4.6
4.8
0.61
55
393
(3051611) Lipemic interference index of Serum or Plasma
13
52
2.52
2.36
2.4
4.7
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
7
17
4.14
2.36
4.6
2.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
30
169
1.80
2.35
1.7
2.4
g/l
1.8
1.3
1.31
25
154
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
125
965
1.34
2.34
1.3
1.2
u/ml
13.0
6.9
0.38
43
390
(3003338) MCHC [Mass/volume]
732
6936
1.28
2.33
24.6
11.5
g/l
334.2
335.2
2.36
727
6877
(3003181) Sodium [Moles/volume] in Urine
14
59
2.39
2.30
1.2
2.9
mmol/l
36.2
77.8
—
9
51
(3026493) Urate [Moles/volume] in Serum or Plasma
154
1229
1.30
2.29
2.4
2.6
umol/l
328.2
3744.3
2.71
131
1132
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
99
2.04
2.27
1.3
2.0
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
99
2.04
2.27
1.3
2.0
g/l
3.8
3.8
0.04
12
74
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
99
2.04
2.27
1.3
2.0
g/l
7.6
7.2
0.39
13
80
(3034988) Calcium [Moles/volume] in Capillary blood
7
18
3.91
2.25
2.3
5.6
mmol/l
1.2
1.2
—
7
18
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
14
60
2.35
2.22
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
14
60
2.35
2.22
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
14
60
2.35
2.22
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
14
60
2.35
2.22
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
14
60
2.35
2.22
1.0
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
16
73
2.21
2.22
1.1
1.6
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
14
61
2.32
2.15
1.0
1.1
—
—
—
0
0
(44813793)
14
61
2.32
2.15
1.1
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
7
19
3.70
2.15
1.1
1.1
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
6
14
4.31
2.15
1.0
1.7
u/l
10.3
13.1
—
6
14
(43055514) Macroprolactin [Presence] in Serum or Plasma
9
30
3.02
2.15
1.2
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
88
655
1.38
2.09
1.2
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
9
31
2.92
2.07
3.4
4.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
89
666
1.37
2.05
1.3
1.2
iu/ml
98.1
160.4
0.89
28
242
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
130
1617
0.77
2.02
1.6
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
17
83
2.07
2.02
1.1
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
34
209
1.65
2.00
2.3
2.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
21
3.35
1.96
1.0
2.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
10
39
2.58
1.92
1.4
1.6
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
39
2.58
1.92
1.2
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
14
65
2.17
1.88
1.1
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
7
22
3.20
1.88
1.7
5.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
31
190
1.65
1.86
2.2
1.9
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
17
86
2.00
1.86
1.7
1.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
20
108
1.87
1.83
2.1
2.3
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
22
123
1.81
1.81
1.4
1.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
62
447
1.42
1.80
1.5
1.7
u/l
9.1
7.0
0.71
48
355
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
47
2.36
1.78
1.2
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
242
2100
1.21
1.72
1.4
1.4
u/ml
1.4
1.9
0.37
62
544
(3013139) Helicobacter pylori Ag [Presence] in Stool
56
400
1.43
1.72
1.2
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
29
454
0.63
1.71
1.2
1.5
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
17
89
1.93
1.70
1.1
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
33
501
0.65
1.70
1.6
1.8
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
23
134
1.74
1.67
1.2
1.3
u/ml
2.6
5.6
—
5
51
(3001019) Free T4 and TSH panel - Serum or Plasma
36
534
0.66
1.67
1.2
1.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
6
19
3.17
1.66
2.2
6.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
36
531
0.66
1.63
1.5
1.6
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
10
43
2.34
1.60
3.7
2.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
215
1858
1.21
1.59
1.4
1.4
g/l
2.0
2.1
0.68
106
1157
(3001122) Ferritin [Mass/volume] in Serum or Plasma
377
3426
1.17
1.56
3.0
2.9
ug/l
74.1
85.3
0.79
350
3232
(40760888) Immunoglobulin light chains.free panel - Serum
10
44
2.29
1.53
1.4
3.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
5
15
3.35
1.52
1.0
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
43
0.00
1.52
0.0
1.3
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
17
93
1.84
1.52
1.4
2.0
g/l
9.7
10.6
0.59
12
85
(4034850)
28
178
1.59
1.50
13.2
7.8
—
—
—
0
0
(40768443) Skin Pathology biopsy report
30
194
1.57
1.50
1.2
1.1
—
—
—
0
0
(4306422)
20
116
1.74
1.49
1.2
1.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
9
37
2.45
1.48
2.2
3.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
20
117
1.73
1.46
1.3
1.7
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
12
59
2.05
1.44
1.3
1.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
61
458
1.36
1.43
4.6
1.9
e9/l
4.8
4.1
1.02
48
403
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
23
141
1.65
1.42
2.3
1.5
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
9
41
2.21
1.37
1.1
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
6
23
2.62
1.37
1.3
2.5
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
6
23
2.62
1.37
1.7
1.9
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
35
240
1.48
1.36
1.9
1.9
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
23
143
1.62
1.36
1.5
1.4
ug/g
289.4
332.1
0.36
11
77
(3045142) Bone marrow Pathology biopsy report
9
42
2.15
1.34
1.1
1.7
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
9
42
2.15
1.34
1.1
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
32
217
1.49
1.32
2.9
2.3
—
—
—
0
0
(4010399)
46
335
1.39
1.32
1.4
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
17
99
1.73
1.28
6.9
5.4
u/ml
0.4
0.3
0.33
11
56
(3051651) Icteric interference index of Serum or Plasma
9
44
2.06
1.27
1.7
5.0
—
—
—
0
0
(4268621)
16
92
1.75
1.25
2.3
2.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
25
2.41
1.24
1.0
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
8
36
2.23
1.24
3.0
1.4
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
9
45
2.01
1.23
1.1
1.8
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
78
622
1.28
1.23
1.3
1.4
—
—
—
0
0
(4062490)
13
71
1.84
1.20
1.3
1.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
21
133
1.59
1.18
1.2
1.3
u/ml
3.5
6.1
—
10
60
(3039443) Prostate specific Ag panel - Serum or Plasma
6
130
0.46
1.16
2.3
1.6
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
13
72
1.82
1.15
1.3
1.3
g/l
6.9
6.1
—
6
51
(3028192) IgG subclass 2 [Mass/volume] in Serum
13
72
1.82
1.15
1.3
1.3
g/l
2.9
2.7
—
6
52
(3024139) IgG subclass 3 [Mass/volume] in Serum
13
72
1.82
1.15
1.3
1.3
g/l
0.4
0.3
—
6
50
(3023323) Follitropin [Units/volume] in Serum or Plasma
60
469
1.30
1.12
1.5
1.6
iu/l
17.7
15.0
0.37
45
371
(3037121) Protein [Mass/volume] in Urine
32
226
1.43
1.11
3.8
4.7
g/l
0.3
0.3
0.10
20
131
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
8
41
1.96
1.09
1.3
2.8
ug/l
26.5
623.1
—
8
35
(3025468) Yersinia sp identified in Specimen by Organism specific culture
13
74
1.77
1.07
1.2
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
9
46
1.97
1.03
2.6
4.7
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
22
2.28
1.03
1.0
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
22
2.28
1.03
1.0
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
13
75
1.74
1.03
1.2
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
13
75
1.74
1.03
1.2
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
13
75
1.74
1.03
1.2
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
13
75
1.74
1.03
1.2
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
39
291
1.36
1.01
1.5
1.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
21
139
1.52
1.01
2.9
3.5
mg/l
13.1
24.0
1.89
11
92
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
9
48
1.88
1.00
1.7
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
13
76
1.72
0.99
1.2
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
9
49
1.84
0.98
1.3
8.9
%
13.6
12.3
—
9
49
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
29
0.00
0.98
0.0
8.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
15
92
1.64
0.97
1.2
1.3
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
30
0.00
0.97
0.0
1.0
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
27
2.23
0.93
1.0
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
10
55
1.83
0.92
1.0
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
28
2.15
0.91
1.5
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
6
28
2.15
0.91
1.2
1.4
nmol/l
126.2
145.8
—
6
28
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
11
63
1.76
0.90
1.3
1.4
nmol/l
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
54
669
0.79
0.88
1.5
2.1
ug/l
0.5
0.6
0.40
30
290
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
8
43
1.87
0.87
2.6
1.7
—
—
—
0
0
(3000492) Spirometry study
61
744
0.81
0.87
1.3
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
8
44
1.83
0.86
2.0
2.0
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
8
45
1.78
0.84
2.0
2.0
mmol/l
106.5
106.3
—
8
45
(4094501)
6
113
0.53
0.83
1.0
1.1
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
8
46
1.75
0.82
2.0
2.0
mmol/l
3.8
4.0
—
8
46
(3029075) Extractable nuclear Ab panel - Serum
6
32
1.88
0.82
1.0
1.0
—
—
—
0
0
(4035726)
43
338
1.29
0.82
1.4
1.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
8
47
1.71
0.80
1.0
1.1
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
33
251
1.33
0.79
2.4
2.1
u/l
35.3
39.3
0.54
28
233
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
6
33
1.82
0.79
1.2
1.4
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
25
0.00
0.79
0.0
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
19
131
1.46
0.79
1.1
1.1
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
12
74
1.63
0.78
1.8
1.4
umol/l
4.8
6.1
0.46
12
68
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
18
123
1.47
0.78
1.3
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
63
523
1.22
0.77
3.3
2.8
%
28.0
31.7
2.18
46
386
(3022145) Colonoscopy Study observation
48
591
0.80
0.76
1.2
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
95
1094
0.85
0.75
1.4
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
54
442
1.24
0.75
1.5
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
24
2.09
0.74
1.4
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
38
1.85
0.73
1.0
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
44
353
1.26
0.73
2.9
2.1
ml/min/173m2
74.9
81.2
0.30
15
134
(40761536) Microorganisms panel - Urine sediment
72
611
1.19
0.71
3.7
3.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
272
2531
1.11
0.71
1.7
1.7
—
—
—
0
0
(4146454)
5
26
1.93
0.70
4.6
3.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
18
126
1.44
0.70
2.8
1.7
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
41
1.71
0.70
1.3
1.6
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
5
93
0.54
0.67
6.4
5.2
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
5
93
0.54
0.67
3.2
2.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
216
1992
1.11
0.67
3.1
2.5
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
29
1.73
0.64
1.2
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
32
252
1.28
0.63
2.3
1.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
22
290
0.75
0.62
1.3
1.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
16
221
0.72
0.60
1.2
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
16
221
0.72
0.60
1.2
1.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
22
287
0.76
0.58
1.3
1.5
u/ml
250.5
207.8
0.39
14
168
(3006442) Creatine [Moles/volume] in Serum or Plasma
8
53
1.51
0.58
1.6
1.3
—
68.9
—
0
7
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
18
132
1.37
0.57
2.6
2.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
41
494
0.82
0.57
2.9
1.9
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
6
36
1.67
0.56
1.7
4.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
25
194
1.30
0.56
1.6
2.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
8
55
1.46
0.56
1.8
1.8
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
51
431
1.19
0.56
1.5
1.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
13
91
1.43
0.53
3.2
2.9
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
39
1.54
0.53
1.3
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
39
1.54
0.53
1.3
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
39
1.54
0.53
1.3
1.6
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
9
63
1.43
0.52
1.4
1.3
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
62
537
1.17
0.52
1.5
1.3
u/ml
841.2
374.6
0.52
56
493
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
14
100
1.41
0.52
1.4
1.9
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
9
135
0.66
0.52
1.6
1.5
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
6
40
1.50
0.51
2.2
1.8
pg
33.2
32.8
—
6
40
(3049717) Cytology report of Urine Cyto stain
13
92
1.42
0.50
2.2
1.7
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
6
41
1.47
0.50
1.7
3.1
u/ml
16.7
21.0
—
6
41
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
68
596
1.15
0.50
1.0
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
19
146
1.31
0.47
3.5
3.9
%
55.5
54.2
0.21
19
146
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
11
154
0.71
0.47
1.5
1.7
mmol/l
7.8
7.1
—
6
96
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
165
0.72
0.46
1.2
1.1
—
—
—
0
0
(3036489) Thrombin time
33
273
1.22
0.46
3.0
3.5
s
20.9
21.6
0.54
24
241
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
8
118
0.68
0.46
2.9
3.7
u/ml
15.1
124.2
—
8
98
(3005033) Fetal Nuchal fold Thickness US
49
422
1.17
0.45
1.4
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
49
424
1.16
0.43
1.4
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
14
104
1.35
0.43
1.4
2.7
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
5
31
1.62
0.43
1.8
2.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
31
1.62
0.43
1.2
1.1
—
—
—
0
0
(4024509)
5
31
1.62
0.43
1.8
1.3
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
29
240
1.22
0.42
2.1
2.5
umol/l
6.3
5.9
0.07
23
187
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
18
228
0.79
0.41
1.5
1.5
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
15
0.00
0.41
0.0
3.5
—
—
—
0
0
(3016031) Almond IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
1.0
—
0
9
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
11
79
1.40
0.41
1.5
1.6
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
18.6
—
0.4
—
0
17
(3024980) IgG subclass 4 [Mass/volume] in Serum
16
123
1.31
0.40
1.6
1.7
g/l
1.3
0.7
—
9
98
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
34
1.47
0.40
1.0
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
12
88
1.37
0.40
1.3
1.7
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.8
—
19.2
—
0
6
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
7
103
0.68
0.39
4.7
1.9
—
—
—
0
0
(3008898) HLA-B27 [Presence]
36
419
0.85
0.38
1.2
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
9
68
1.33
0.37
2.3
3.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
9
68
1.33
0.37
1.2
1.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
18
143
1.26
0.37
3.4
3.6
e9/l
3.5
3.8
0.25
18
143
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
70
1.29
0.36
2.0
4.4
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
5
76
0.66
0.36
1.0
1.0
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
25
208
1.21
0.35
2.6
1.9
iu/l
3.7
5.2
—
10
81
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
43
1.40
0.35
2.0
2.5
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
11
82
1.35
0.34
1.4
1.3
—
37.1
—
0
5
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
683
6933
0.94
0.33
4.0
3.8
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
24
283
0.84
0.31
1.2
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
57
1.23
0.29
1.6
1.9
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
9
121
0.74
0.27
1.1
1.3
pmol/l
44.6
56.1
—
9
116
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
13
104
1.25
0.26
1.0
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
31
273
1.14
0.25
1.1
1.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
30
340
0.88
0.25
1.0
1.2
u/ml
0.8
1.5
0.64
14
160
(3025018) Bordetella pertussis Ab [Titer] in Serum
9
76
1.19
0.24
1.0
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
29
255
1.14
0.24
1.3
1.6
iu/ml
0.0
0.3
—
7
45
(3038177) Helicobacter pylori Ab [Presence] in Serum
16
133
1.21
0.24
1.2
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
54
589
0.91
0.24
1.3
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
92
863
1.07
0.24
1.7
2.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
30
265
1.14
0.24
1.7
1.7
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
37
333
1.12
0.22
1.6
1.7
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
42
1.19
0.21
1.0
1.2
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
5
42
1.19
0.21
1.4
1.1
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
0
11
0.00
0.21
0.0
1.0
—
7.8
—
0
11
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3006598) pH of Arterial cord blood
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3021706) Oxygen [Partial pressure] in Arterial cord blood
0
11
0.00
0.21
0.0
1.0
—
3.0
—
0
11
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
2.0
—
2.5
—
0
11
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3033882) Carnitine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.9
—
36.2
—
0
10
(3011436) Histone Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
12
0.00
0.21
0.0
2.8
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
8
101
0.79
0.21
1.3
1.1
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
13
0.00
0.21
0.0
3.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
14
166
0.84
0.20
1.1
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
10
80
1.25
0.20
1.3
1.9
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
65
696
0.93
0.20
1.4
1.4
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
3.1
—
1.2
—
0
14
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
17
146
1.17
0.19
1.4
1.7
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
7
60
1.17
0.18
1.1
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
61
1.15
0.17
1.6
1.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
111
1160
0.95
0.17
2.5
2.8
ug/l
8.7
1.4
0.50
100
1064
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
66
0.76
0.17
1.2
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
67
0.74
0.17
1.2
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
17
148
1.15
0.17
1.4
1.8
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
16
139
1.15
0.16
3.5
6.3
—
2469.6
—
0
11
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
57
535
1.07
0.16
1.4
1.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
8
71
1.13
0.16
1.1
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
222
2162
1.04
0.16
1.8
1.8
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
9
79
1.14
0.15
1.2
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
90
0.78
0.14
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
57
538
1.06
0.14
1.4
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
10
84
1.19
0.14
1.6
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
57
539
1.06
0.13
1.4
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
57
539
1.06
0.13
1.4
1.4
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
20
222
0.90
0.13
1.2
1.1
u/ml
8.9
5.6
—
8
105
(3032773) Endomysium IgG Ab [Titer] in Serum
9
110
0.82
0.13
1.2
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
30
277
1.09
0.13
1.2
1.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
18
200
0.90
0.12
1.1
1.1
u/ml
18.6
6.3
—
8
101
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
33
354
0.93
0.12
1.3
1.8
mg/l
4.4
4.1
0.09
25
233
(3048689) Calprotectin [Mass/mass] in Stool
124
1203
1.04
0.11
1.8
2.8
ug/g
95.6
118.1
0.49
93
949
(21494815) CD4 cells/100 lymphocytes in Specimen
11
95
1.16
0.11
3.0
2.8
—
47.0
—
0
10
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
28
301
0.93
0.11
1.4
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
136
1324
1.03
0.11
1.6
1.5
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
77
741
1.04
0.10
2.5
2.1
nmol/l
12.6
13.2
0.20
66
677
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
13
115
1.13
0.10
1.0
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
67
644
1.04
0.10
1.1
1.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
44
1.14
0.10
1.0
1.1
iu/ml
152.0
193.6
—
5
44
(3035933) Granulocytes/100 leukocytes in Blood
5
44
1.14
0.10
14.8
1.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
44
1.14
0.10
1.2
1.4
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
6
54
1.11
0.09
58.3
33.2
ug/l
8.9
7.1
—
6
49
(3004616) Nuclear Ab [Presence] in Serum
6
58
1.03
0.08
1.2
1.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
60
0.83
0.08
1.0
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
28
297
0.94
0.08
1.0
1.1
u/ml
5.0
1.0
0.40
17
150
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
8
75
1.07
0.07
1.6
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
84
0.83
0.07
7.4
4.4
—
—
—
0
0
(44806118)
9
84
1.07
0.07
1.6
1.8
—
—
—
0
0
(44790047)
9
84
1.07
0.07
1.6
1.8
—
—
—
0
0
(44790049)
9
84
1.07
0.07
1.6
1.7
—
—
—
0
0
(44790048)
9
84
1.07
0.07
1.6
1.8
—
—
—
0
0
(40768793) Breast Pathology biopsy report
9
85
1.06
0.07
1.1
1.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
21
223
0.94
0.06
1.9
1.6
u/ml
99.1
92.9
—
6
37
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
10
90
1.11
0.05
1.1
1.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
22
231
0.95
0.04
1.6
1.9
u/ml
36.0
38.0
0.04
22
220
(1002224) Polysomnography panel
35
339
1.03
0.03
1.2
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
24
230
1.04
0.03
1.8
1.6
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
61
600
1.02
0.02
1.5
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
11
103
1.07
0.02
1.3
1.3
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
28
287
0.97
0.01
1.1
1.1
u/ml
6.3
3.2
—
8
84
(3009542) Hematocrit [Volume Fraction] of Blood
741
7403
1.01
0.00
21.0
10.1
%
40.1
41.2
3.51
575
6337
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
18
184
0.98
0.00
1.1
1.1
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
24
242
0.99
0.00
4.2
4.0
g/l
3.4
3.3
0.18
24
233
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
97
1.03
0.00
1.5
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
18
181
0.99
0.00
1.9
2.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
18
179
1.01
0.00
1.2
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
31
305
1.02
0.00
1.0
1.1
u/ml
8.8
8.3
0.04
19
190
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
88
885
0.99
0.00
2.7
2.7
%
19.4
21.4
0.37
24
244
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
61
0.98
0.00
1.5
1.6
—
—
—
0
0
(40760512) CD34 cells/100 cells in Bone marrow
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
6.0
—
3.5
—
0
7
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
2.3
—
4.2
—
0
9
(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.0
—
29.8
—
0
9
(3019174) dRVVT (LA screen)
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022670) pH of Venous cord blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
8
89
0.90
0.00
1.0
1.2
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
6
0.00
0.00
0.0
10.7
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
7
79
0.89
0.00
2.9
3.1
e9/l
0.2
0.2
—
7
63
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020093) Fractional oxyhemoglobin in Venous cord blood
0
5
0.00
0.00
0.0
1.0
—
72.2
—
0
5
(3044009) aPTT.lupus sensitive (LA screen)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
0.4
—
0
9
(3028717) Thiamine [Mass/volume] in Blood
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
71
0.99
0.00
1.6
1.7
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
57
0.88
0.00
1.0
1.1
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
66
0.91
0.00
1.0
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
76
0.92
0.00
1.6
1.8
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
7
79
0.89
0.00
2.9
3.1
e6/l
579.9
525.8
—
7
62
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
57
0.88
0.00
1.0
1.1
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
7
0.00
0.00
0.0
11.9
—
—
—
0
0
(3000936) Kiwifruit IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
1.1
—
0
5
(3013762) Body weight Measured
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: F5_CONDUCT – Conduct disorder
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).